Case Comprehensive Cancer Center: Neoplasms, Plasma Cell trials
The registry lists 14 Neoplasms, Plasma Cell studies with Case Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 1 2Phase 2 6Phase 3 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00941720Phase 2Results posted
- Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCTWithdrawnNCT04685525Not applicable
- Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMTCompletedNCT04194840Not applicable
- Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering MyelomaWithdrawnNCT03591614Early Phase 1
- Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic CancerTerminatedNCT00918658
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
- Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationCompletedNCT00281801
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesCompletedNCT00068523Not applicable
- Brostallicin in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNCT00060203Phase 1/2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Non-Ablative Allo HSCT For Hematologic Malignancies or SAACompletedNCT00006379Phase 2
- O6-benzylguanine And Carmustine in Treating Patients With Multiple MyelomaCompletedNCT00004072Phase 2
- High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2